Effects of the immobilization of heparin and rhPDGF-BB to titanium surfaces for the enhancement of osteoblastic functions and anti-inflammation
0
조회
0
다운로드
3
인용
0
참고문헌
초록
PURPOSE. This study was to investigate the effects of recombinant human platelet-derived growth factor (rhPDGF-BB) and heparin to titanium surfaces for enhancement of osteoblastic functions and inhibition of inflammation activity. MATERIALS AND METHODS. The anodized titanium discs, not coated with any material, were used as a control group. In heparinized- Ti group, dopamine was anchored to the surface of Ti substrates, and coated with heparin. In PDGF-Ti group, rhPDGF-BB was immobilized onto heparinized Ti surface. The surface morphologies were investigated by the scanning electron microscope in each group. The release kinetics of rhPDGF-BB were analyzed, and cytotoxicity tests for each group were conducted. The biocompatibilities were characterized by measuring cell proliferation, alkaline phosphatase activity, and calcium deposition using MG-63 cells. Statistical comparisons were carried out by one-way ANOVA tests. Differences were considered statistically significant at *P<.05 and **P<.001. RESULTS. The combination of rhPDGF-BB and heparin stimulated alkaline phosphatase activity and OCN mRNA expression in osteoblastic cells (*P<.05 and **P<.001). MG-63 cells grown on PDGF-Ti had significantly higher amounts of calcium deposition than those grown on anodized Ti (**P<.001). Heparinized Ti was more anti-inflammatory compared to anodized Ti, when exposed to lipopolysaccharide using the transcript levels of TNF-αand IL-6 of proinflammatory cytokine (*P<.05 and **P<.001). CONCLUSION. The result of this study demonstrated that the incorporation of rhPDGF-BB and heparin onto Ti surface enhanced osteoblastic functions and inhibited inflammation.
Abstract
PURPOSE. This study was to investigate the effects of recombinant human platelet-derived growth factor (rhPDGF-BB) and heparin to titanium surfaces for enhancement of osteoblastic functions and inhibition of inflammation activity. MATERIALS AND METHODS. The anodized titanium discs, not coated with any material, were used as a control group. In heparinized- Ti group, dopamine was anchored to the surface of Ti substrates, and coated with heparin. In PDGF-Ti group, rhPDGF-BB was immobilized onto heparinized Ti surface. The surface morphologies were investigated by the scanning electron microscope in each group. The release kinetics of rhPDGF-BB were analyzed, and cytotoxicity tests for each group were conducted. The biocompatibilities were characterized by measuring cell proliferation, alkaline phosphatase activity, and calcium deposition using MG-63 cells. Statistical comparisons were carried out by one-way ANOVA tests. Differences were considered statistically significant at *P<.05 and **P<.001. RESULTS. The combination of rhPDGF-BB and heparin stimulated alkaline phosphatase activity and OCN mRNA expression in osteoblastic cells (*P<.05 and **P<.001). MG-63 cells grown on PDGF-Ti had significantly higher amounts of calcium deposition than those grown on anodized Ti (**P<.001). Heparinized Ti was more anti-inflammatory compared to anodized Ti, when exposed to lipopolysaccharide using the transcript levels of TNF-αand IL-6 of proinflammatory cytokine (*P<.05 and **P<.001). CONCLUSION. The result of this study demonstrated that the incorporation of rhPDGF-BB and heparin onto Ti surface enhanced osteoblastic functions and inhibited inflammation.
참고문헌 (30)
- Rezania A, "The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells", J Biomed Mater Res, 52, pp.595~600 (2000)
- Bab I, "Osteogenic growth peptide: from concept to drug design", Biopolymers, 66, pp.33~48 (2002)
- Giannobile WV, "Periodontal tissue engineering by growth factors", Bone, 19, pp.23~37 (1996)
- Park YJ, "Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration", J Control Release, 51, pp.201~211 (1998)
- Camelo M, "Periodontal regeneration in human Class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft", Int J Periodontics Restorative Dent, 23, pp.213~225 (2003)
- Nevins ML, "Evaluation of periodontal regeneration following grafting intrabony defects with bio-oss collagen: a human histologic report", Int J Periodontics Restorative Dent, 23, pp.9~17 (2003)
- Nevins M, "Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone", J Periodontol, 74, pp.1282~1292 (2003)
- Nevins M, "Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial", J Periodontol, 76, pp.2205~2215 (2005)
- Lynch SE, "The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing", J Periodontol, 62, pp.458~467 (1991)
- Lynch SE, "A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration", J Clin Periodontol, 16, pp.545~548 (1989)
- Bolander ME, "Regulation of fracture repair by growth factors", Proc Soc Exp Biol Med, 200, pp.165~170 (1992)
- Andrew JG, "Platelet-derived growth factor expression in normally healing human fractures", Bone, 16, pp.455~460 (1995)
- Fujii H, "Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse", Histochem Cell Biol, 112, pp.131~138 (1999)
- Nash TJ, "Effect of platelet-derived growth factor on tibial osteotomies in rabbits", Bone, 15, pp.203~208 (1994)
- Mitlak BH, "The effect of systemically administered PDGF-BB on the rodent skeleton", J Bone Miner Res, 11, pp.238~247 (1996)
- Sasisekharan R, "On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans", Angiogenesis, 1, pp.45~54 (1997)
- Perets A, "Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres", J Biomed Mater Res A, 65, pp.489~497 (2003)
- Ishibe T, "Bone formation on apatite-coated titanium with incorporated BMP-2", heparin in vivo, 2009, pp.108, 867~875
- Young E, "The anti-inflammatory effects of heparin and related compounds", Thromb Res, 122, pp.743~752 (2008)
- von Walter M, "Biomimetic modification of the TiO2", glass composite Ecopore with heparinized collagen and the osteoinductive factor BMP-2, 2008, pp.4, 997~1004
- Kodama T, "Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin", Int J Oral Maxillofac Implants, 23, pp.1013~1019 (2008)
- Kim SE, "The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function", BIOMATERIALS, 32, pp.366~373, ELSEVIER SCI LTD
- Clark AE, "The influence of surface chemistry on implant interface histology: a theoretical basis for implant materials selection", J Biomed Mater Res, 10, pp.161~174 (1976)
- Puleo DA, "Understanding and controlling the bone-implant interface", Biomaterials, 20, pp.2311~2321 (1999)
- De Giglio E, "analytical characterization, and osteoblast adhesion properties on RGD-grafted polypyrrole coatings on titanium substrates", J Biomater Sci Polym Ed, 11, pp.1073~1083 (2000)
- Tosatti S, "Peptide functionalized poly(L-lysine)-g-poly(ethylene glycol) on titanium: resistance to protein adsorption in full heparinized human blood plasma", Biomaterials, 24, pp.4949~4958 (2003)
- Damsky CH, "Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling", Bone, 25, pp.95~96 (1999)
- Turksen K, "Isolation of monoclonal antibodies recognizing rat bone-associated molecules in vitro and in vivo", J Histochem Cytochem, 40, pp.1339~1352 (1992)
- van den Beucken JJ, "Functionalization of multilayered DNAcoatings with bone morphogenetic protein 2", J Control Release, 113, pp.63~72 (2006)
- Hochart H, "Low molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes", Br J Haematol, 133, pp.62~67 (2006)